昆虫抗菌肽基因工程及其分子设计研究进展(英文)

昆虫抗菌肽是昆虫免疫后存在于血淋巴中的一类活性肽,具有广谱抗菌的生物活性,因而昆虫抗菌肽基因工程迅速成为生命科学领域的研究热点之一.介绍了昆虫抗菌肽的基因结构和表达,综述了昆虫抗菌肽的人工合成与改造以及转基因工程的研究成果,概述了昆虫抗菌肽的分子设计方法和现状,并展望了昆虫抗菌肽的应用前景.     

昆虫抗菌肽分类及在医学中应用

昆虫是地球上种类最为繁多的生物,其抗菌肽的种类和应用范围也远多于其他生物产生的抗菌肽。随着越来越多昆虫抗菌肽的发现及对其深入的研究,昆虫抗菌肽的结构和作用机制也被逐一阐明,并广泛应用于畜牧、食品工业及医药等领域。然而,由于某些限制因素,昆虫抗菌肽还未应用于临床。为了加快昆虫抗菌肽在临床中的应用,本文将从昆虫抗菌肽的结构分类、潜在的医学应用以及昆虫抗菌肽的生产研究现状等方面作一综述,以期为昆虫抗菌肽在抗细菌、抗病毒、抗肿瘤及抗寄生虫药物等方面的医用研发提供文献支持。     

昆虫抗茵肽的生理活性及其转基因应用前景

昆虫抗菌肽是昆虫免疫后存在于血淋巴中的一类活性肽.根据分子的结构可分为5类天蚕素类、昆虫防御素、富含脯氨酸或精氨酸的抗菌肽、富含甘氨酸的抗菌肽、抗真菌肽.且具有广谱的抗菌、抗病毒、抑制肿瘤的生物活性.概述了昆虫抗菌肽的基因的克隆与表达及转基因研究方面的进展,并展望了抗菌肽在基因工程中的应用前景.     

昆虫抗菌肽对肿瘤细胞的抑制作用研究进展

昆虫抗菌肽(antimicrobial peptide,AMPs)是一类昆虫先天免疫系统中十分重要的效应因子,它分子量小、热稳定,并且具有广谱抗菌性,能够抑制、杀死多种细菌、真菌.近几年来,由于昆虫抗菌肽具有抗肿瘤的活性且其不具有抗原性而受到研究者的广泛关注.昆虫种类多、分布广,因此昆虫抗菌肽具有很高的开发潜力和实际应用价值.但是,目前对于昆虫抗菌肽抗肿瘤能力的研究尚不够深入,对其作用机制还没有一套准确并且系统的理论.现在普遍认为昆虫抗菌肽的抗肿瘤机制与其抗菌机制类似,可以分为破坏细胞膜机制以及非破坏细胞膜机制,并且同一种昆虫抗菌肽可以通过多种方式来抑制甚至杀死肿瘤细胞,但是对正常真核细胞无明显的毒副作用.相较于传统化疗药物的无差别杀伤,昆虫抗菌肽在肿瘤治疗领域有着巨大潜力.本文简要综述了昆虫抗菌肽对肿瘤细胞的抑制作用及其作用机制,并对其开发潜力和实际应用价值进行了展望,以期为今后的研究提供理论支持.     

昆虫抗菌肽对肿瘤细胞的抑制作用研究进展

昆虫抗菌肽(antimicrobial peptide,AMPs)是一类昆虫先天免疫系统中十分重要的效应因子,它分子量小、热稳定,并且具有广谱抗菌性,能够抑制、杀死多种细菌、真菌.近几年来,由于昆虫抗菌肽具有抗肿瘤的活性且其不具有抗原性而受到研究者的广泛关注.昆虫种类多、分布广,因此昆虫抗菌肽具有很高的开发潜力和实际应用价值.但是,目前对于昆虫抗菌肽抗肿瘤能力的研究尚不够深入,对其作用机制还没有一套准确并且系统的理论.现在普遍认为昆虫抗菌肽的抗肿瘤机制与其抗菌机制类似,可以分为破坏细胞膜机制以及非破坏细胞膜机制,并且同一种昆虫抗菌肽可以通过多种方式来抑制甚至杀死肿瘤细胞,但是对正常真核细胞无明显的毒副作用.相较于传统化疗药物的无差别杀伤,昆虫抗菌肽在肿瘤治疗领域有着巨大潜力.本文简要综述了昆虫抗菌肽对肿瘤细胞的抑制作用及其作用机制,并对其开发潜力和实际应用价值进行了展望,以期为今后的研究提供理论支持.     

昆虫抗菌肽的研究进展

昆虫抗菌肽是昆虫先天免疫中起重要的作用的一类免疫效应因子,具有广谱抗菌、抗病毒、抑制肿瘤的生物活性和很好应用前景.本文主要介绍昆虫抗菌肽的类型、抗菌机理和分子设计的研究进展.     

昆虫抗菌肽的结构和功能研究现状

昆虫抗菌肽是昆虫血淋巴中的一类活性肽。在昆虫感染病菌或体壁受到损伤的情况下其脂肪体能迅速合成一系列抗菌活性物质并释放到血淋巴中发挥作用,抑杀多种致病菌、真菌、病毒等,但不破坏生物体的正常细胞。对昆虫抗菌肽的结构特征、生物活性及抗菌肽分子的作用模式的最新研究进展作了综述。     

昆虫抗菌肽结构、性质和基因调控

昆虫抗菌肽是昆虫先天免疫系统中非常重要的一类效应分子。昆虫抗菌肽带正电荷,分子量小,大多数少于100个氨基酸残基。根据结构可以将昆虫抗菌肽分为一些不同的家族。昆虫抗菌肽不同的抗菌谱表明,它具有不同的作用机制。以果蝇为模式生物研究表明,昆虫抗菌肽的基因调控涉及到多个信号通路及大量的信号分子。     

昆虫抗菌肽的生理活性及其转基因应用前景

昆虫抗菌肽是昆虫免疫后存在于血淋巴中的一类活性肽。根据分子的结构可分为 5类 :天蚕素类、昆虫防御素、富含脯氨酸或精氨酸的抗菌肽、富含甘氨酸的抗菌肽、抗真菌肽。且具有广谱的抗菌、抗病毒、抑制肿瘤的生物活性。概述了昆虫抗菌肽的基因的克隆与表达及转基因研究方面的进展 ,并展望了抗菌肽在基因工程中的应用前景     

昆虫抗菌肽研究现状与展望

昆虫抗菌肽具有分子量小、热稳定性强、无免疫原性、生物活性广泛等特点,在医药、农业、食品工业等领域逐渐显示出广阔的应用前景,特别是在当前大量耐药性菌株的出现,而新抗生素发现又极其困难的情况下．昆虫抗菌肽的潜在药用价值倍受人们关注。本文将对昆虫抗菌肽的结构特征,抗菌机理．基因工程及其应用前景等知识作一简要介绍。     

The inducible antibacterial peptides of insects

Insects respond to bacterial challenge by the rapid and transient synthesis of a large number of potent antibacterial peptides that are active against many different bacteria. Two families of inducible antibacterial peptides are well characterized: the cecropins and the insect defensins. A rapidly increasing number of proline- and glycine-rich peptides are reported from various insect species together with cecropins and insect defensins. In this review, Stéphane Cociancich, Philippe Bulet, Charles Hetru and Jules A. Hoffmann give an update of our current information on the induced antibacterial peptides.     

昆虫抗菌肽及其基因工程研究进展

昆虫抗菌肽是昆虫免疫后存在于血淋巴中的一类活性肽,具有广谱的抗菌、抗病毒、抑制肿瘤的生物活性,具有很高的应用潜力。本文主要介绍昆虫抗菌肽的类型、生理活性、基因的克隆与表达及转基因工程研究进展。 Insect Antibacterial Peptides and Its Progress in Advance on Genetic Engineering GONG Xia,YUE Guo-wei,SHI Yong-hui Laboratory for Animal Nutrition Research,College of Food Science,Southern Yangtze University,Wuxi 214036,China Abstract:Insect antibacterial peptides produced are kinds of bioactive peptides in hameolymph hen insect has been immunized.These peptides have the wide range of antibacterial,antiviral spectrum and inhibiting growth of tumor cell.The types of antibacterial peptides and its physiological activities,cloning and expression of the genes and transgenetic research are summarized.Its application on medicine and gene engineering are prospected. Key words：insect antibacterial peptides; physiological activity; gene     

Antibacterial peptides isolated from insects.

Insects are amazingly resistant to bacterial infections. To combat pathogens, insects rely on cellular and humoral mechanisms, innate immunity being dominant in the latter category. Upon detection of bacteria, a complex genetic cascade is activated, which ultimately results in the synthesis of a battery of antibacterial peptides and their release into the haemolymph. The peptides are usually basic in character and are composed of 20-40 amino acid residues, although some smaller proteins are also included in the antimicrobial repertoire. While the proline-rich peptides and the glycine-rich peptides are predominantly active against Gram-negative strains, the defensins selectively kill Gram-positive bacteria and the cecropins are active against both types. The insect antibacterial peptides are very potent: their IC50 (50% of the bacterial growth inhibition) hovers in the submicromolar or low micromolar range. The majority of the peptides act through disintegrating the bacterial membrane or interfering with membrane assembly, with the exception of drosocin, apidaecin and pyrrhocoricin which appear to deactivate a bacterial protein in a stereospecific manner. In accordance with their biological function, the membrane-active peptides form ordered structures, e.g. alpha-helices or beta-pleated sheets and often cast permeable ion-pores. Their cytotoxic properties were exploited in in vivo studies targeting tumour progression. Although the native peptides degrade quickly in biological fluids other than insect haemolymph, structural modifications render the peptides resistant against proteases without sacrificing biological activity. Indeed, a pyrrhocoricin analogue shows lack of toxicity in vitro and in vivo and protects mice against experimental Escherichia coli infection. Careful selection of lead molecules based on the insect antibacterial peptides may extend their utility and produce viable alternatives to the conventional antimicrobial compounds for mammalian therapy.     

Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity

Lepidoptera have been reported to produce several antibacterial peptides in response to septic injury. However, in marked contrast to other insect groups, no inducible antifungal molecules had been described so far in this insect order. Surprisingly, also cysteine-rich antimicrobial peptides, which predominate in the antimicrobial defense of other insects, had not been discovered in Lepidoptera. Here we report the isolation from the hemolymph of immune induced larvae of the lepidopteran Heliothis virescens of a cysteine-rich molecule with exclusive antifungal activity. We have fully characterized this antifungal molecule, which has significant homology with the insect defensins, a large family of antibacterial peptides directed against Gram-positive strains. Interestingly, the novel peptide shows also similarities with the antifungal peptide drosomycin from Drosophila. Thus, Lepidoptera appear to have built their humoral immune response against bacteria on cecropins and attacins. In addition, we report that Lepidoptera have conferred antifungal properties to the well conserved structure of antibacterial insect defensins through amino acid replacements.     

Isolation, characterization and chemical synthesis of a new insect defensin from Chironomus plumosus (Diptera)

Injection of low doses of bacteria into the aquatic larvae of the dipteran insect Chironomus plumosus induces the appearance in their hemolymph of a potent antibacterial activity. We have isolated two 36-residue peptides from this hemolymph which are active against Gram-positive bacteria. The peptides are novel members of the insect defensin family and their sequences present marked differences with those of insect defensins isolated from other dipteran species. We have developed a method for efficient renaturation of this cysteine-rich molecule and obtained a highly pure synthetic Chironomus defensin.     

Novel antibacterial peptides induced by probiotics in Hermetia illucens (Diptera: Stratiomyidae) larvae

There is a need to discover new therapeutic substances due to the emergence of deadly infectious diseases and various antibiotic resistance. We focused on the larvae that are utilized as a medical insect for the treatment of skin damage in Europe and America. This study was to investigate the pharmacological activities of novel antibacterial peptides isolated from Hermetia illucens larvae against the Klebsiella pneumoniae and Shigella dysenteriae. The larvae were immunized by probiotics (Lactobacillus casei) for 24 h. The hemolymph from the immunized larvae was fractionated through reverse‐phase chromatography. Peptides were purified using HPLC and the coomassie blue staining, and identified using Nano‐LC‐ESI‐MS/MS system. Antibacterial activities of the peptides were evaluated by turbidometric assay, liquid broth dilution assay, resazurin assay, and agar disk diffusion method. The minimum inhibitory concentrations (MICs) of the peptides were measured as 150 μg/mL through the turbidometric, liquid broth dilution, and resazurin assays. The peptides effectively inhibited their growth/proliferation as well as the survival rate of the tested bacteria. Furthermore, the immunized larvae exhibited overexpression of the peptides compared to non‐immunized larvae. These results demonstrate that the peptides induced by H. illucens exert strong antibacterial activity against Gram‐negative bacteria. The results suggest that the activation of the humoral immunity induced by immunization functioned to enhance the production of antibacterial peptides from the insect and their antibacterial properties. This study indicates the potential of the peptides produced from larvae as antibacterial peptide substance for the development of novel antibacterial drugs.